The Use of Poly-L-Lysine as a Capture Agent to Enhance the Detection of Antinuclear Antibodies by ELISA

• Published in: PloS one 2016-09, Vol.11 (9), p.e0161818-e0161818
• Main Authors: Stearns, Nancy A, Zhou, Shuxia, Petri, Michelle, Binder, Steven R, Pisetsky, David S
• Format: Article
• Language: English
• Subjects: Antibodies; Antibodies, Antinuclear - chemistry; Antigens; Antinuclear antibodies; Apoptosis; Apoptosis - genetics; Apoptosis - physiology; Arthritis; Assaying; Autoimmune diseases; Biology and Life Sciences; Chronic conditions; Clinical trials; Coating; Deoxyribonuclease I - metabolism; Deoxyribonucleic acid; Disease; DNA; DNA - chemistry; DNA binding proteins; Enzyme-Linked Immunosorbent Assay; Enzymes; Fluorescent antibody technique; Gene expression; Histones; Hostages; Humans; Immunoassay; Immunofluorescence; Immunoglobulins; Immunology; In vivo methods and tests; Jurkat Cells; Laboratories; Lupus; Lysine; Medical research; Medicine and Health Sciences; Multiplexing; Nobel, Alfred Bernhard (1833-96); Nucleosomes - metabolism; Physical Sciences; Poly-L-lysine; Polylysine - chemistry; Polymers; Proteins; Research and Analysis Methods; Rheumatology; Ribonucleic acid; RNA; Systemic lupus erythematosus
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0161818

Antibodies to nuclear antigens (antinuclear antibodies or ANAs) are the serological hallmark of systemic lupus erythematosus (SLE). These antibodies bind diverse nuclear antigens that include DNA, histones and non-histone proteins as well as complexes of proteins with DNA and RNA. Because of the frequency of ANA expression in SLE, testing is an important component of clinical evaluation as well as determination of eligibility for clinical trials or utilization of certain therapies. Immunofluorescence assays have been commonly used for this purpose although this approach can be limited by issues of throughput, variability and difficulty in determining positivity. ELISA and multiplex assays are also useful approaches although these assays may give an incomplete picture of antibodies present. To develop a sensitive and quantitative ANA assay, we have explored an ELISA platform in which plates are pre-coated with a positively charged nucleic acid binding polymer (NABP) to increase adherence of antigens containing DNA or RNA. As a source of antigens, we have used supernatants of Jurkat cells undergoing apoptosis in vitro. As results presented show, a poly-L-lysine (PLL) pre-coat significantly enhances detection of antibodies to DNA as well as antigens such as histones, SSA, SSB and RNP. Comparison of the ELISA assay with the PLL pre-coat with a multiplex assay using the BioPlex® 2200 system indicated good agreement in results for a panel of lupus sera. Together, these studies indicate that a pre-coat with a positively charged polymer can increase the sensitivity of an ANA ELISA using as antigens molecules released from dead and dying cells. This assay platform may facilitate ANA testing by providing an ensemble of antigens more similar in composition and structure with antigens present in vivo, with a NABP promoting adherence via charge-charge interactions.